Alzheimer’s disease accelerates Social Security insolvency risk and strains Medicare and Medicaid. Early diagnosis and innovative treatments offer potential economic benefits. Policy action is needed to sustain healthcare programs and workforce participation.
Analysis reveals how advance care planning visits influenced treatment outcomes for Medicare beneficiaries during the COVID-19 pandemic, offering insights for healthcare strategy in emergencies.
House Republicans plan to block ACA subsidy extensions, risking higher premiums for millions and impacting U.S. health insurance market stability. Insights on policy and regulatory implications.
Advanced AI-driven network toxicology reveals molecular mechanisms of Benzo[a]pyrene's role in lung adenocarcinoma, informing regulatory and health risk frameworks.
Latest US federal policy updates on HUD Continuum of Care funding, Senate health bills on premium tax credits, DOJ changes to Title VI enforcement, and CMS 2026 eligibility standards affecting older adults.
CMS announces ACCESS, a voluntary 10-year model offering outcome-based payments for technology-supported chronic care management, enhancing Medicare value-based care.
Turquoise Health’s 2025 report evaluates payer machine-readable file quality and price transparency across 97 insurers, revealing data conflicts and gaps in reimbursement reporting.
ACA premium subsidies set to expire soon threaten to double costs for millions and cause coverage losses unless Congress acts by Dec 15 enrollment deadline.
The Trump administration's CMS decision excludes costly obesity treatments from Medicare coverage, highlighting challenges in drug pricing and healthcare policy reforms.
CMS has indefinitely suspended federally funded nursing home ownership reporting due to PECOS system issues, delaying the revalidation deadline and advising ongoing data collection. Key updates on regulatory compliance for Medicare and Medicaid providers.
